Medimak Pharma LLP
About Medimak Pharma LLP
Data last updated:
Medimak Pharma LLP is a limited liability partnership (LLP) based in Chennai, Tamil Nadu, India. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 05 October 2018 and has been in existence for over 8 years.
The LLP is registered with the Registrar of Companies (ROC), Chennai, under LLPIN AAN-4058. Its GSTIN is 33ABKFM0633J1ZD (Tamil Nadu).
The LLP has a total obligation of contribution of ₹1.5 Lakh. It is led by designated partners including Mahendra Kumar and Surendra Chopra.
Its latest statement of accounts is for the year ended 31 March 2023. The registered office is at Old No.23 New No.41 Ground Floor 1st & 2nd Floor Pantheon Road Egmore, Chennai, Tamil Nadu, India – 600008.
As per MCA filings, the LLP has open charges of ₹5 Cr and satisfied charges of ₹2.5 Cr on record. Court records list 2 cases involving the LLP, including 2 filed by the LLP; 1 case is pending.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressOld No.23 New No.41 Ground Floor 1st & 2nd Floor Pantheon Road Egmore, Chennai, Tamil Nadu, India – 600008
- IndustryHealthcare, Medical Equipment Retail & Distribution
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Medimak Pharma LLP FY 2023 filings available
Financial Statement Summary of Medimak Pharma LLP
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Income | •••• | •••• | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• | •••• | •••• |
| Profit After Tax | •••• | •••• | •••• | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• | •••• | •••• |
| Assets and Liabilities | |||||
| Partners' Contribution | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Medimak Pharma LLP
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Medimak Pharma are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Designated Partners of Medimak Pharma LLP
Medimak Pharma has 3 designated partners on record. No former designated partners are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mahendra Kumar Also directs: Makers Pharma Private Limited | Designated Partner | 05 Oct 2018 | 8 Years 0 Months | Current |
| Surendra Chopra | Designated Partner | 05 Oct 2018 | 8 Years 0 Months | Current |
| Sarthak Chopra | Designated Partner | 05 Oct 2018 | 8 Years 0 Months | Current |
Charges & Borrowings of Medimak Pharma LLP
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 May 2025 | Idfc First Bank Limited | ₹5 Cr | Open |
| 30 Jun 2020 | Kotak Mahindra Bank Limited | ₹2.5 Cr | Satisfied |
Total charge records: 2 View all charges
Legal Cases of Medimak Pharma LLP
Medimak Pharma LLP has 2 court cases on record: 2 filed by Medimak Pharma. 1 case is pending and 1 is disposed. Status as checked on 21 Sep 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 0 | 1 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Chennai, Tamil Nadu | Court case (COS) | Filed by the company against Harsha Management Services Private Limited | Disposed |
| District court, Chennai, Tamil Nadu | Criminal case | Filed by the company against an individual | Pending |
Full case history
All 2 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Medimak Pharma LLP
Employment history and EPFO contributions of people linked to Medimak Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Medimak Pharma LLP
Medimak Pharma LLP has 3 designated partner changes on record since 2018: 3 appointments. The latest: Mahendra Kumar was appointed as Designated Partner on 05 Oct 2018.
Credit Ratings, Litigation & Regulatory Alerts for Medimak Pharma LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Medimak Pharma LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Medimak Pharma LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Medimak Pharma LLP
Medimak Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33ABKFM0633J1ZD | Tamil Nadu | Active | 28 Nov 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Medimak Pharma LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Medimak Pharma LLP
Medimak Pharma is an active limited liability partnership based in Chennai, Tamil Nadu, India. The LLP works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 05 October 2018 (8+ years old) and is registered under LLPIN AAN-4058.
Medimak Pharma has 3 current designated partners:
- Mahendra Kumar - Designated Partner
- Surendra Chopra - Designated Partner
- Sarthak Chopra - Designated Partner
The GSTIN of Medimak Pharma is 33ABKFM0633J1ZD, registered in Tamil Nadu.
The LLPIN (Limited Liability Partnership Identification Number) of Medimak Pharma is AAN-4058. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Medimak Pharma has 2 court cases on record: 2 filed by the LLP. 1 is pending.
Medimak Pharma was incorporated on 05 October 2018, making it 8+ years old. It is registered with the Registrar of Companies, Chennai.
Mahendra Kumar was appointed as Designated Partner on 05 Oct 2018. Sarthak Chopra was appointed as Designated Partner on 05 Oct 2018. Surendra Chopra was appointed as Designated Partner on 05 Oct 2018.
The registered office of Medimak Pharma is at Old No.23 New No.41 Ground Floor 1st & 2nd Floor Pantheon Road Egmore, Chennai, Tamil Nadu, India – 600008.
The total obligation of contribution is ₹1.5 Lakh.
Medimak Pharma operates in the healthcare industry, in the medical equipment retail and distribution segment.